This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mummert, M. E. Articles by Takashima, A. Search for Related Content PubMed PubMed Citation Articles by Mummert, M. E. Articles by Takashima, A.

Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9069

² To whom requests for reprints should be addressed, at Department of Dermatology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9069. E-mail: mark.mummert{at}utsouthwestern.edu

Although hyaluronan (HA), a high molecular weight glycosaminoglycan, is generally believed to regulate tumor growth, invasion, and metastasis, functional roles of HA have only been speculated indirectly from the outcome of blocking HA receptors (e.g., CD44). Using a phage display technique, we recently developed a synthetic peptide (GAHWQFNALTVR; Pep-1) that binds to and inhibits the function of HA. In this study, we have used Pep-1 to determine whether HA directly regulates the behavior of tumor cells. B16-F10 melanoma cells, which constitutively expressed CD44, showed significant adhesion to HA-coated plates, and this adhesion was blocked almost completely either by neutralizing antibodies against CD44 or by Pep-1. These results imply that CD44 is the primary HA receptor mediating the adhesive interaction of the melanoma cells with HA substrates. In contrast, Pep-1 failed to inhibit in vitro proliferation of B16-F10 melanoma cells or the in vitro growth of the cells after s.c. inoculation in mice. Importantly, single injection of Pep-1 significantly reduced the incidence of lung metastasis of i.v. inoculated melanoma cells and prolonged the survival of the tumor-bearing animals. These results suggest a direct contribution of HA to one or more steps in the initial seeding of melanoma cells in the lung microenvironment. Our observations also introduce a new concept that synthetic inhibitors of HA may represent unique tools for studying the roles of HA in tumor biology and perhaps a new class of therapeutic reagents.

This article has been cited by other articles:

				A. Nobumoto, K. Nagahara, S. Oomizu, S. Katoh, N. Nishi, K. Takeshita, T. Niki, A. Tominaga, A. Yamauchi, and M. Hirashima Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices Glycobiology, September 1, 2008; 18(9): 735 - 744. [Abstract] [Full Text] [PDF]

				Y. Kim, Y.-S. Lee, J. Choe, H. Lee, Y.-M. Kim, and D. Jeoung CD44-Epidermal Growth Factor Receptor Interaction Mediates Hyaluronic Acid-promoted Cell Motility by Activating Protein Kinase C Signaling Involving Akt, Rac1, Phox, Reactive Oxygen Species, Focal Adhesion Kinase, and MMP-2 J. Biol. Chem., August 15, 2008; 283(33): 22513 - 22528. [Abstract] [Full Text] [PDF]

				H. Guan, P. S. Nagarkatti, and M. Nagarkatti Blockade of Hyaluronan Inhibits IL-2-Induced Vascular Leak Syndrome and Maintains Effectiveness of IL-2 Treatment for Metastatic Melanoma J. Immunol., September 15, 2007; 179(6): 3715 - 3723. [Abstract] [Full Text] [PDF]

				E. Avin, J. Haimovich, and N. Hollander Anti-Idiotype x Anti-CD44 Bispecific Antibodies Inhibit Invasion of Lymphoid Organs by B Cell Lymphoma J. Immunol., October 1, 2004; 173(7): 4736 - 4743. [Abstract] [Full Text] [PDF]

				D. Coradini, S. Zorzet, R. Rossin, I. Scarlata, C. Pellizzaro, C. Turrin, M. Bello, S. Cantoni, A. Speranza, G. Sava, et al. Inhibition of Hepatocellular Carcinomas in vitro and Hepatic Metastases in vivo in Mice by the Histone Deacetylase Inhibitor HA-But Clin. Cancer Res., July 15, 2004; 10(14): 4822 - 4830. [Abstract] [Full Text] [PDF]